Epi.Ax

EPI.AX has a negative equity position of -37,593,610 AUD and a debt-to-equity ratio of -1.5, indicating a highly leveraged capital structure. The company's liquidity is rated as medium, with a current ratio of 0.78, suggesting that it may struggle to meet short-term obligations without additional financing. The company's market capitalization is 78,001,794.72 AUD, and its enterprise value to revenue ratio is 301.86, which is significantly higher than typical for the industry, indicating a high valuation relative to its revenue.

In terms of profitability, EPI.AX reported a net income of -31,778,980 AUD and an operating income of -29,835,830 AUD, both of which are negative, indicating that the company is not currently profitable. The return on equity is 0.8453, which is positive but very low, and the return on assets is -1.4057, indicating that the company is not effectively utilizing its assets to generate profit. These metrics are below the industry median for profitability, suggesting that EPI.AX is underperforming its peers in terms of financial returns.

EPI.AX's revenue is concentrated in a single segment, as disclosed in its financial statements, with no significant geographic diversification reported. The company's revenue is primarily derived from its operations in Australia, and there is no indication of substantial international revenue streams. This concentration increases the company's exposure to local market conditions and regulatory changes, which could impact its financial performance.

The company's growth trajectory is uncertain, with no clear indication of revenue growth in the current fiscal year. The operating cash flow is negative at -16,977,160 AUD, and the free cash flow is also negative at -31,749,140 AUD, indicating that the company is not generating sufficient cash to fund its operations or expansion. The capital expenditure of -38,150 AUD is minimal, suggesting that the company is not investing heavily in new projects or infrastructure.

The risk assessment for EPI.AX indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could lead to liquidity constraints. However, the dilution risk is low, as there is no indication of significant share issuance or dilution potential. The company's financial position is further complicated by its negative equity and high debt levels, which could limit its ability to secure additional financing.

Recent events and filings do not provide a clear picture of the company's strategic direction or financial health. The company's financial statements show a consistent pattern of losses and negative cash flows, which may raise concerns among investors and creditors. The lack of positive financial performance and the absence of significant capital expenditures suggest that the company may be facing operational or market challenges.